Wattiez A-S, Sowers LP, Russo AF (2020) Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets 24(2):91–100
Article
CAS
Google Scholar
Dodick DW (2019) CGRP ligand and receptor monoclonal antibodies for migraine prevention: evidence review and clinical implications. Cephalalgia 39(3):445–458
Article
Google Scholar
Hargreaves R, Olesen J (2019) Calcitonin gene-related peptide modulators - the history and renaissance of a new migraine drug class. Headache 59(6):951–970. https://doi.org/10.1111/head.13510
Article
PubMed
Google Scholar
Eftekhari S, Warfvinge K, Blixt FW, Edvinsson L (2013) Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain 14(11):1289–1303
Article
CAS
Google Scholar
Warfvinge K, Edvinsson L (2019) Distribution of CGRP and CGRP receptor components in the rat brain. Cephalalgia 39(3):342–353
Article
Google Scholar
Uddman R, Edvinsson L, Ekblad E, Håkanson R, Sundler F (1986) Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept 15(1):1–23
Article
CAS
Google Scholar
Cooper GJ (1994) Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev 15(2):163–201
Article
CAS
Google Scholar
Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD (2015) Amylin: pharmacology, physiology, and clinical potential. Pharmacol Rev 67(3):564–600
Article
CAS
Google Scholar
McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393(6683):333–339
Article
CAS
Google Scholar
Cottrell GS, Alemi F, Kirkland JG, Grady EF, Corvera CU, Bhargava A (2012) Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract. Peptides 35(2):202–211
Article
CAS
Google Scholar
Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, Edvinsson L (2010) Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169(2):683–696
Article
CAS
Google Scholar
Zimmermann U, Fluehmann B, Born W, Fischer J, Muff R (1997) Coexistence of novel amylin-binding sites with calcitonin receptors in human breast carcinoma MCF-7 cells. J Endocrinol 155:423–431
Article
CAS
Google Scholar
Shi L, Lehto SG, Zhu DX, Sun H, Zhang J, Smith BP, Immke DC, Wild KD, Xu C (2016) Pharmacologic characterization of AMG 334, a potent and selective human monoclonal antibody against the calcitonin gene-related peptide receptor. J Pharmacol Exp Ther 356(1):223–231
Article
CAS
Google Scholar
Bhakta M, Vuong T, Taura T, Wilson DS, Stratton JR, Mackenzie KD (2021) Migraine therapeutics differentially modulate the CGRP pathway. Cephalalgia 41(5):499–514
Article
Google Scholar
Pan KS, Siow A, Hay DL, Walker CS (2020) Antagonism of CGRP signaling by rimegepant at two receptors. Front Pharmacol:1240. https://doi.org/10.3389/fphar.2020.01240
Jespersen T, Grunnet M, Angelo K, Klaerke D, Olesen S-P (2002) Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes. Biotechniques 32(3):536–540
Article
CAS
Google Scholar
Booms A, Coetzee GA, Pierce SE (2019) MCF-7 as a model for functional analysis of breast cancer risk variants. Cancer Epidemiol Prev Biomarkers 28(10):1735–1745
Article
CAS
Google Scholar
Jansen-Olesen I, Jørgensen L, Engel U, Edvinsson L (2003) In-depth characterization of CGRP receptors in human intracranial arteries. Eur J Pharmacol 481(2-3):207–216
Article
CAS
Google Scholar
Jansen-Olesen I, Mortensen A, Edvinsson L (1996) Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia 16(5):310–316
Article
CAS
Google Scholar
Walker CS, Eftekhari S, Bower RL, Wilderman A, Insel PA, Edvinsson L, Waldvogel HJ, Jamaluddin MA, Russo AF, Hay DL (2015) A second trigeminal CGRP receptor: function and expression of the AMY 1 receptor. Ann Clin Transl Neurol 2(6):595–608
Article
CAS
Google Scholar
Walker CS, Raddant AC, Woolley MJ, Russo AF, Hay DL (2018) CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured. Cephalalgia 38(3):437–451
Article
Google Scholar
King CT, Gegg CV, Hu SN-Y, Sen LH, Chan BM, Berry KA, Brankow DW, Boone TJ, Kezunovic N, Kelley MR (2019) Discovery of the migraine prevention therapeutic aimovig (Erenumab), the first FDA-approved antibody against a G-protein-coupled receptor, vol 2. ACS Publications, pp 485–490. https://doi.org/10.1021/acsptsci.9b00061
Book
Google Scholar
Hay D, Christopoulos G, Christopoulos A, Sexton P (2004) Amylin receptors: molecular composition and pharmacology. Biochem Soc Trans 32(5):865–867
Article
CAS
Google Scholar
ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA, Lepre CA, Garcia-Guzman M, Moore JM (2010) Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18(9):1083–1093
Article
Google Scholar
Szkutnik-Fiedler D (2020) Pharmacokinetics, pharmacodynamics and drug–drug interactions of new anti-migraine drugs—Lasmiditan, gepants, and calcitonin-gene-related peptide (CGRP) receptor monoclonal antibodies. Pharmaceutics 12(12):1180. https://doi.org/10.3390/pharmaceutics12121180
Article
CAS
PubMed Central
Google Scholar
Croop R, Ivans A, Anderson MS, Stringfellow J, Bertz R, Hanna M, Healy F, Stock DA, Coric V, Lipton RB (2021) A phase 1 randomized study of hemodynamic effects and pharmacokinetic interactions during concomitant use of rimegepant and sumatriptan in healthy adults. Cephalalgia Rep 4:25158163211007922. https://doi.org/10.1177/25158163211007922
Article
Google Scholar
Vu T, Ma P, Chen JS, de Hoon J, Van Hecken A, Yan L, Wu LS, Hamilton L, Vargas G (2017) Pharmacokinetic-pharmacodynamic relationship of erenumab (AMG 334) and capsaicin-induced dermal blood flow in healthy and migraine subjects. Pharm Res 34(9):1784–1795. https://doi.org/10.1007/s11095-017-2183-6
Article
CAS
PubMed
PubMed Central
Google Scholar
de Vries LS, Verhagen IE, van den Hoek TC, MaassenVanDenBrink A, Terwindt GM (2021) Treatment with the monoclonal calcitonin gene-related peptide receptor antibody erenumab: a real-life study. Eur J Neurol 28(12):4194–4203
Article
Google Scholar
Holzer P, Holzer-Petsche U (2021) Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related Peptide’s motor-stimulating and Prosecretory function in the intestine. Front Physiol 12:820006. https://doi.org/10.3389/fphys.2021.820006
Kanaan S, Hettie G, Loder E, Burch R (2020) Real-world effectiveness and tolerability of erenumab: a retrospective cohort study. Cephalalgia 40(13):1511–1522
Article
Google Scholar
Lambru G, Hill B, Murphy M, Tylova I, Andreou AP (2020) A prospective real-world analysis of erenumab in refractory chronic migraine. J Headache Pain 21(1):1–10
Article
Google Scholar
Gates T, Zimmerman R, Mantyh C, Vigna S, Mantyh PW (1989) Calcitonin gene-related peptide-α receptor binding sites in the gastrointestinal tract. Neuroscience 31(3):757–770
Article
CAS
Google Scholar
Grider J (1994) CGRP as a transmitter in the sensory pathway mediating peristaltic reflex. American journal of physiology-gastrointestinal and liver. Physiology 266(6):G1139–G1145
CAS
Google Scholar
Liberini CG, Boyle CN, Cifani C, Venniro M, Hope BT, Lutz TA (2016) Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons. Eur J Neurosci 43(5):653–661
Article
Google Scholar
Mulder H, Ekelund M, Ekblad E, Sundler F (1997) Islet amyloid polypeptide in the gut and pancreas: localization, ontogeny and gut motility effects. Peptides 18(6):771–783
Article
CAS
Google Scholar
Young A (2005) Inhibition of gastric emptying. Adv Pharmacol 52:99–121
Article
CAS
Google Scholar
Hay DL, Christopoulos G, Christopoulos A, Poyner DR, Sexton PM (2005) Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Mol Pharmacol 67(5):1655–1665
Article
CAS
Google Scholar
Falkenberg K, Bjerg HR, Olesen J (2020) Two-hour CGRP infusion causes gastrointestinal hyperactivity: possible relevance for CGRP antibody treatment. Headache: the journal of head and face. Pain 60(5):929–937
Google Scholar
Kraenzlin M, Ch'Ng J, Mulderry P, Ghatei M, Bloom S (1985) Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones. Regul Pept 10(2-3):189–197
Article
CAS
Google Scholar
Dos Santos JBR, da Silva MRR (2022) Small molecule CGRP receptor antagonists for the preventive treatment of migraine: a review. Eur J Pharmacol 922:174902
Article
CAS
Google Scholar